Episode 58: PYLARIFY® Injection PET/CT Imaging in Prostate Cancer Patient for UroNurse

Marco Carlos MA, Patient Navigator at Urology of Austin will discuss PYLARIFY® (piflufolastat F 18) Injection used in PET/CT imaging for the detection of prostate cancer in patients. PYLARIFY is a diagnostic imaging agent that contains the radioactive isotope fluorine-18 (F 18) attached to a molecule called piflufolastat. This radiopharmaceutical is used to visualize specific biological processes in the body. Prostate cancer cells have an increased expression of a molecule called prostate-specific membrane antigen (PSMA). PYLARIFY is designed to bind to PSMA receptors on the surface of prostate cancer cells. By attaching F 18 to piflufolastat, PYLARIFY can be detected using positron emission tomography (PET) imaging, which produces detailed images of the distribution of this radiopharmaceutical in the body. *The information provided in this video is for entertainment and educational purposes only, and does not constitute medical advice. Consult a medical professional or healthcare provider if you are seeking medical advice, diagnoses, or treatment. #prostate #prostatecancer #petscan